174 related articles for article (PubMed ID: 31418468)
21. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
[TBL] [Abstract][Full Text] [Related]
22. N-acetylcysteine- and MK-801-induced changes in glutamate levels do not affect in vivo binding of metabotropic glutamate 5 receptor radioligand 11C-ABP688 in rat brain.
Wyckhuys T; Verhaeghe J; Wyffels L; Langlois X; Schmidt M; Stroobants S; Staelens S
J Nucl Med; 2013 Nov; 54(11):1954-61. PubMed ID: 24050937
[TBL] [Abstract][Full Text] [Related]
23. Radiosynthesis of N-(4-chloro-3-[(11)C]methoxyphenyl)-2-picolinamide ([(11)C]ML128) as a PET radiotracer for metabotropic glutamate receptor subtype 4 (mGlu4).
Kil KE; Zhang Z; Jokivarsi K; Gong C; Choi JK; Kura S; Brownell AL
Bioorg Med Chem; 2013 Oct; 21(19):5955-62. PubMed ID: 23978356
[TBL] [Abstract][Full Text] [Related]
24. Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [11C]ABP688 Positron-Emission Tomography (PET) Imaging.
DuBois JM; Rousset OG; Guiot MC; Hall JA; Reader AJ; Soucy JP; Rosa-Neto P; Kobayashi E
Cereb Cortex; 2016 Oct; 26(11):4170-4179. PubMed ID: 27578494
[TBL] [Abstract][Full Text] [Related]
25. Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology.
Hashimoto H; Kawamura K; Igarashi N; Takei M; Fujishiro T; Aihara Y; Shiomi S; Muto M; Ito T; Furutsuka K; Yamasaki T; Yui J; Xie L; Ono M; Hatori A; Nemoto K; Suhara T; Higuchi M; Zhang MR
J Nucl Med; 2014 Sep; 55(9):1532-8. PubMed ID: 24963128
[TBL] [Abstract][Full Text] [Related]
26. Radiosynthesis and validation of [Carboxy-
Holt DP; Kalinda AS; Bambarger LE; Jain SK; Dannals RF
J Labelled Comp Radiopharm; 2019 Jan; 62(1):28-33. PubMed ID: 30089334
[TBL] [Abstract][Full Text] [Related]
27. In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5.
DeLorenzo C; DellaGioia N; Bloch M; Sanacora G; Nabulsi N; Abdallah C; Yang J; Wen R; Mann JJ; Krystal JH; Parsey RV; Carson RE; Esterlis I
Biol Psychiatry; 2015 Feb; 77(3):266-275. PubMed ID: 25156701
[TBL] [Abstract][Full Text] [Related]
28. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.
DuBois JM; Rousset OG; Rowley J; Porras-Betancourt M; Reader AJ; Labbe A; Massarweh G; Soucy JP; Rosa-Neto P; Kobayashi E
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):152-162. PubMed ID: 26290423
[TBL] [Abstract][Full Text] [Related]
29. Radiosynthesis of the
Teyssier VR; Simard JM; Dornan MH; Tournoux F; DaSilva JN
J Labelled Comp Radiopharm; 2020 Feb; 63(2):65-71. PubMed ID: 31912556
[TBL] [Abstract][Full Text] [Related]
30. Radiosynthesis and validation of [5-cyano-N-(4-(4-[
Mathews WB; Wu Y; Horti AG; Naik R; Hall AW; Holt DP; Dannals RF
J Labelled Comp Radiopharm; 2019 Nov; 62(13):903-908. PubMed ID: 31524293
[TBL] [Abstract][Full Text] [Related]
31. Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [
Streffer J; Treyer V; Buck A; Ametamey SM; Blagoev M; Maguire RP; Gautier A; Auberson YP; Schmidt ME; Vranesic IT; Gomez-Mancilla B; Gasparini F
Neuroimage; 2021 Apr; 230():117785. PubMed ID: 33545349
[TBL] [Abstract][Full Text] [Related]
32. Radiosynthesis of a carbon-11 labeled PDE5 inhibitor [
Xu Z; Jia L; Liu W; Li W; Song Y; Zheng QH
Appl Radiat Isot; 2020 Aug; 162():109190. PubMed ID: 32501230
[TBL] [Abstract][Full Text] [Related]
33. Radiosynthesis and Preclinical Investigation of
Forgács V; Németh E; Gyuricza B; Kis A; Szabó JP; Mikecz P; Mátyus P; Helyes Z; Horváth ÁI; Kálai T; Trencsényi G; Fekete A; Szikra D
ChemMedChem; 2020 Dec; 15(24):2470-2476. PubMed ID: 32935925
[TBL] [Abstract][Full Text] [Related]
34. Molecular Imaging of mGluR5 Availability with [
Kosten L; Deleye S; Stroobants S; Wyffels L; Mingote S; Rayport S; Staelens S
Cell Mol Neurobiol; 2019 Mar; 39(2):255-263. PubMed ID: 30552621
[TBL] [Abstract][Full Text] [Related]
35. Test-retest variability of [
Smart K; Cox SML; Nagano-Saito A; Rosa-Neto P; Leyton M; Benkelfat C
Synapse; 2018 Sep; 72(9):e22041. PubMed ID: 29935121
[TBL] [Abstract][Full Text] [Related]
36. A simple and efficient automated cGMP-compliant radiosynthesis of [
Kovac M; Miklovicz T; Li L; Russell J; Canales Candela R; Aigbirhio F; Boros I
J Labelled Comp Radiopharm; 2019 Apr; 62(4):190-197. PubMed ID: 30690759
[TBL] [Abstract][Full Text] [Related]
37. Novel
Li S; Cai Z; Zheng MQ; Holden D; Naganawa M; Lin SF; Ropchan J; Labaree D; Kapinos M; Lara-Jaime T; Navarro A; Huang Y
J Nucl Med; 2018 Jan; 59(1):140-146. PubMed ID: 28747521
[TBL] [Abstract][Full Text] [Related]
38. Automated radiosynthesis of 5-[
Rosenberg AJ; Nickels ML; Schulte ML; Manning HC
Nucl Med Biol; 2018 Dec; 67():10-14. PubMed ID: 30359787
[TBL] [Abstract][Full Text] [Related]
39. Radiosynthesis of carbon-11 labeled PDE5 inhibitors as new potential PET radiotracers for imaging of Alzheimer's disease.
Dong F; Du J; Miao C; Jia L; Li W; Wang M; Zheng QH; Xu Z
Appl Radiat Isot; 2019 Dec; 154():108873. PubMed ID: 31470193
[TBL] [Abstract][Full Text] [Related]
40. The automated radiosynthesis and purification of the opioid receptor antagonist, [6-O-methyl-11C]diprenorphine on the GE TRACERlab FXFE radiochemistry module.
Fairclough M; Prenant C; Brown G; McMahon A; Lowe J; Jones A
J Labelled Comp Radiopharm; 2014 May; 57(5):388-96. PubMed ID: 24692062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
